The Harvard Dermatopathology Program is a ACGME-accredited fellowship training program that draws on the facilities of the Beth Israel Deaconess Medical Center, the Brigham and Women's Hospital, and Massachusetts General Hospital. The period of fellowship is one year. Fellows enter the program eligible for Board certification in dermatology or pathology and receive one-half of their training in the complementary fields of anatomic pathology or clinical dermatology, respectively. Additionally, fellows receive training in dermatoimmunopathology, immunofluorescence, microbiology/mycology, tissue processing for both routine and specialized microscopy, diagnostic electron microscopy, immunohistochemistry, and laboratory management.Clinical and translational research opportunities are available throughout the program. Fellows have abundant opportunities to attend a wide variety of clinical and pathological-diagnostic conferences, and are required to teach in training programs offered to residents and medical students.
The Brigham and Women's Program in Dermatopathology is a component of the Harvard Dermatopathology Program that consists of closely integrated diagnostic and research units. The Diagnostic Service analyzes daily a large number of diverse and complex specimens derived from the Brigham and Women's clinical practices as well as the Dana Farber Cancer Institute. The Service is supported by comprehensive special diagnostic laboratories that provide a vast array of immunohistochemical and molecular probes. The Research Division occupies a complementary facility conducting NIH-funded investigation focused on molecular and cellular pathways responsible for cutaneous cytotoxicity as well as on melanocyte/melanoma stem cell biology. Thus there exist ample resources for potential participation in translational research that complement acquisition of basic diagnostic skills requisite for dermatopathology practice. BWH faculty mentors are actively involved in didactic initiatives, including authorship participation in a number of dermatopathology texts, including the most recent editions of Pathology of the Skin (McKee, Calonje, Granter) and Lever's Histology of the Skin (Elder, Elenitsas, Johnson, Murphy).
Requirements: Fellowship candidates must be graduates of approved medical schools in the United States or Canada. Graduates of foreign medical schools must have an ECFMG Certificate. Applicants must have completed a residency training program in either Pathology or Dermatology and be eligible for certification in either one to enter the program.
Stipends: Based on Postgraduate level of trainee
Faculty: Michael Atkins MD Director, Cutaneous Oncology Program, BIDMC; Laura C. Collins MD Director, Pathology Residency Training Program, BIDMC; Madhu Dahiya MD Dermatopathologist; Lyn M. Duncan MD Associate Professor of Pathology, Dermatopathologist; melanoma and hyperplasia research; Thomas J. Flotte MD Associate Professor of Dermatology; Chief, Dermatopathology Unit, MGH; Dermatopathologist; laser tissue interaction, biology of pigmented lesions; Scott R. Granter MD Associate Professor of Pathology, Dermatopathologist; diagnostic dermatopathology, melanocytic nevi; melanoma and inflammatory dermatoses; Harley A. Haynes MD Dermatologist; cutaneous oncology; Brian Jiang MD Mohs surgeon; Dermatologist; Richard A. Johnson MD Dermatologist; HIV infection and epidemiology, Lyme borreliosis; Lara Kelley MD Dermatologist; Mohs surgeon; Christina Kendrick MD Dermatologist; Thomas S. Kupper MD Dermatologist; molecular biology, cutaneous T-cell lymphoma; Joseph Kvedar MD Dermatologist; Paul Levins MD Dermatologist; Vincent Liu MD Dermatopathologist; Stephen R. Lyle MD, PhD, Dermatopathologist; alopecia and hair follicle biology; melanoma and appendageal tumors; Martin C. Mihm Jr. MD Clinical Professor of Pathology; biology of melanoma, precursors and problematic lesions; delayed hypersensitivity response; pathogenesis of vasculitis; molecular biology of pigmentation; lymphoma;George Murphy MD Professor of Pathology, Director of BWH Program in Dermatopathology; cutaneous cytotoxicity and skin stem cells; Victor Neel MD Mohs surgeon, Dermatology; Thuy Phung MD, PhD Dermatopathologist; German Pihan MD Hematopathologist; Abrar Quereshi MD Dermatologist; Rachel Reynolds MD Dermatologist; Brigitta Schmidt MD Pediatric Dermatopathologist; Arthur J. Sober MD Dermatologist; melanoma and dysplastic nevi; Robert Stern MD Dermatologist; psoriasis; Artur Zembowicz MD, PhD Dermatopathologist and ENT pathology; Mary Jane Zimarowski MD Dermatopathologist.
Address inquiries to:
Joan Allin, Coordinator, Harvard Dermatopathology Fellowship Program,
Pathology Department Beth Israel Deaconess Medical Center, 330 Brookline Avenue
Boston, MA 02215 Email: email@example.com
Send Feedback to: Glenn Spiro
This page was last modified on 10/19/2011